# Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)

> **NCT05700695** · PHASE1 · COMPLETED · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 114 (actual)

## Conditions studied

- Hepatic Encephalopathy
- Acute-On-Chronic Liver Failure

## Interventions

- **DRUG:** Branch Chain Amino Acid
- **DRUG:** Lactulose

## Key facts

- **NCT ID:** NCT05700695
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-17
- **Primary completion:** 2025-06-05
- **Final completion:** 2025-06-05
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05700695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05700695, "Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05700695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*